Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who had secondary upper extremity lymphedema due to mastectomy secondary upper extremity lymphedema due to adjuvant therapy secondary upper extremity lymphedema stage I and II only
Exclusion criteria
Exclusion criteria: not willing to participate in the study developed absolute contraindications like cellulitis, acute infection, CHF, CVI & Renal failure. unable to attend the OPD alternate days for CDT therapy during the intensive phase of treatment. developed Primary upper extremity lymphedema.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of Lymphedema measuerd by caliberated measuring tapeTimepoint: Day - 0 Day- 15 Day -30 Day -60 | — |
Secondary
| Measure | Time frame |
|---|---|
| Resuming household activities Non complaince to bandages Side effects Timepoint: Day after starting the therapy Up to 30 days | — |
Countries
India
Contacts
AIIMS Bhubaneswar